ANDREA RANDALL: Open Payments
NPI 1821409467 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,241 in 314 payments from 34 companies in 2025. Trend: 2023 $5,227 · 2024 $6,634 · 2025 $6,241
Food & beverage: $5,325Travel & lodging: $807Education: $87Speaker / faculty: $22
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 15 | $1,122 |
| ABBVIE INC. | 74 | $912 |
| PFIZER INC. | 34 | $428 |
| MDD US Operations, LLC | 27 | $407 |
| Novartis Pharmaceuticals Corporation | 9 | $328 |
| UCB, Inc. | 17 | $311 |
| ARGENX US, INC. | 11 | $229 |
| SK Life Science, Inc. | 10 | $204 |
| EMD Serono, Inc. | 8 | $192 |
| LivaNova USA, Inc. | 3 | $185 |
Products named: PERCEPT PC BRAINSENSE, UBRELVY, KESIMPTA, NURTEC ODT, QULIPTA, VYVGART HYTRULO, Apokyn, VNS THERAPY SENTIVA MODEL 1000 GENERATOR.
Industry payments across IN — which companies pay providers there.
